FindTrial
Sign In

Study on the Effect of Preventive Rivaroxaban on Catheter Thrombosis in Patients with Indwelling Intravenous Access for Gynecological Tumors

The effect of rivaroxaban prophylaxis anticoagulation on catheter-related thrombosis in outpatients with gynecological malignancies who had a Khorana score of 1 and were discharged with PICC or infusion port: A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126619
Enrollment
Unknown
Registered
2026-06-12
Start date
2026-06-12
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related thrombosis in patients with gynecological tumors

Interventions

Observation group:None

Sponsors

Fujian Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Outpatients diagnosed with gynecological malignant tumors; 2. With a Khorana score of 1; 3. Discharged with PICC or infusion port; 4. Age >=18 years; 5. Complete medical records, with full follow-up records.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of previous venous thromboembolism; 2. Severe liver and kidney dysfunction (Child-Pugh grade C or creatinine clearance <30 mL/min); 3. Expected survival period of <3 months; 4. Incomplete medical records or lost to follow-up; 5. Concurrent use of other anticoagulant drugs.

Design outcomes

Primary

MeasureTime frame
CRT occurrence;—

Secondary

MeasureTime frame
The incidence and risk factors of catheter-related thrombosis;The safety of rivaroxaban for preventive anticoagulation;—

Countries

China

Contacts

Public ContactXie Qing

Fujian Maternity and Child Health Hospital

1456340756@qq.com+86 591 8755 7800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026